| | | | | |
AGIO Agios Pharmaceuticals, Inc. | $28,9350 | +4,53% | $1,74B | $133,66K | |
SGRY Surgery Partners, Inc. Common Stock | $13,7950 | +2,11% | $1,74B | $379,73K | |
GAB The Gabelli Equity Trust Inc. | $5,5950 | -0,27% | $1,74B | $555,60K | |
HURN Huron Consulting Group Inc. | $107,69 | +2,75% | $1,74B | $25,11K | |
ENVX Enovix Corporation Common Stock | $8,3050 | +0,91% | $1,74B | $2,89M | |
PAYO Payoneer Global Inc. Common Stock | $5,2050 | +2,26% | $1,74B | $1,10M | |
ETV Eaton Vance Tax-Managed Buy-Write Opportunities Fund | $14,9200 | +0,07% | $1,73B | $66,39K | |
STGW Stagwell Inc. Class A Common Stock | $6,7350 | +2,20% | $1,73B | $309,77K | |
CASH Pathward Financial, Inc. Common Stock | $78,5400 | +1,03% | $1,73B | $58,74K | |
SNDX Syndax Pharmaceuticals, Inc. | $17,9210 | -2,28% | $1,73B | $4,48M | |
STRA Strategic Education, Inc. Common Stock | $81,5350 | +3,14% | $1,73B | $67,72K | |
CAPR Capricor Therapeutics Inc | $28,3730 | +2,65% | $1,73B | $213,27K | |
AAPG Ascentage Pharma Group International American Depository Shares | $18,4210 | +3,08% | $1,73B | $1,72K | |
SLS SELLAS Life Sciences Group, Inc. Common Stock | $8,8650 | +8,24% | $1,73B | $3,49M | |
PLSE Pulse Biosciences, Inc Common Stock (DE) | $27,5450 | +10,22% | $1,73B | $279,86K | |
